Talk2gether Program for Social Connection in Older Adults
19 augusti 2026 uppdaterad av: Jason Burnett, The University of Texas Health Science Center, Houston
Talk2gether Program
The purpose of this study is to see if it is feasible to recruit and retain older adults in a, weekly phone call program delivered through the Harris County Precinct 2 Healthcare and Social Services Team and to see how participation in the program affect older adults' loneliness, social isolation, psychological well-being, and satisfaction, and what barriers or challenges arise during implementation
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Beräknad)
50
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Jason Burnett, PhD
- Telefonnummer: (713) 873-4685
- E-post: Jason.Burnett@uth.tmc.edu
Studera Kontakt Backup
- Namn: Jordan Broussard
- Telefonnummer: 713 500 0321
- E-post: Jordan.Broussard@uth.tmc.edu
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77030
- The University of Texas Health Science Center at Houston
-
Kontakt:
- Jason Burnett, PhD
- Telefonnummer: 713-873-4685
- E-post: Jason.Burnett@uth.tmc.edu
-
Kontakt:
- Jordan Broussard
- Telefonnummer: (713) 500-0321
- E-post: Jordan.Broussard@uth.tmc.edu
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- able to provide informed consent
- able to speaks English or Spanish
- able to hear sufficiently using the telephone
Exclusion Criteria:
- Need for another person to consent on the participant's behalf
- suspected or confirmed decision-making capacity impairments
- uncontrolled psychiatric illnesses such as schizophrenia, paranoia, delusion, or delirium
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Talk2gether program
|
Participants will be paired with a trained team member.
The team member will then initiate contact with the older adult(s) to begin 90 days of weekly social calls.
These weekly social calls will be mostly unstructured, but supported by resource and conversation guides.
At the end of 90 days, if the older adult wishes to continue to receive calls, that request will be accommodated
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Program Feasibility as assessed by number of participants recruited
Tidsram: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
|
|
Program Feasibility as assessed by number of participants that adhered to the weekly calls
Tidsram: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
|
|
Feasibility as assessed by number of participants that completed the program
Tidsram: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
|
|
Feasibility as assessed by number of participants that encountered barriers or challenges as assessed by the Client Satisfaction Questionnaire (CSQ-8)
Tidsram: end of intervention (90 days after baseline)
|
This is an 8 item questionnaire and Items 2, 4, 5, and 8 are reverse scored.
Total scores range from 8 to 32, with the higher number indicating greater satisfaction
|
end of intervention (90 days after baseline)
|
|
Feasibility as assessed by number of participants that encountered barriers or challenges as reported on the Caller and Older Adult feedback form
Tidsram: end of intervention (90 days after baseline)
|
end of intervention (90 days after baseline)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in social connectedness as assessed by the Lubben Social Network Scale-6
Tidsram: baseline, post-intervention (Day 90)
|
This is a 6-item self-report measure assessing perceived social support and social network size from family and friends.
Each item is scored from 0 to 5, and total scores range from 0 to 30.
Higher scores indicate greater social connectedness and lower risk of social isolation
|
baseline, post-intervention (Day 90)
|
|
Change in loneliness as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation scale
Tidsram: Baseline, end of intervention (90 days)
|
This is an 8 item scale.
Each item is rated on a 5-point scale from 1(never) to 5 ( always).
Raw scores range from 8 to 40 and are converted to PROMIS T-scores, with a mean of 50 and standard deviation of 10 in the reference population.
Higher scores indicate greater perceived social isolation/loneliness.
|
Baseline, end of intervention (90 days)
|
|
Change in depressive symptoms as assessed by the Patient Health Questionnaire-2
Tidsram: Baseline, end of intervention (90 days)
|
This is a 2-item self-report measure .
Each item is scored from 0 (not at all) to 3 (nearly every day).
Total scores range from 0 to 6, with higher scores indicating greater depressive symptom burden.
|
Baseline, end of intervention (90 days)
|
|
Change in signs of elder mistreatment as assessed by the Elder Mistreatment Screening and Response Tool (EM-SART).
Tidsram: Baseline, end of intervention (90 days)
|
This is a 3 item questionnaire and each will be scored as either 1(yes) or 0(no) for a maximum score of 3. Higher scores or more endorsed concerns indicate a greater number of signs suggestive of elder mistreatment
|
Baseline, end of intervention (90 days)
|
|
Change in sense of purpose using the 7-item Ryff Purpose in Life Scale.
Tidsram: Baseline, end of intervention (90 days)
|
This is a 7 item questionnaire and each item is rated on a Likert-type scale, commonly from 1(strongly disagree) to 6( strongly agree).
Negatively worded items are reverse scored, and item scores are summed to generate a total score.
Total scores range from 7 to 42, with higher scores indicating a greater sense of purpose in life.
|
Baseline, end of intervention (90 days)
|
|
Client satisfaction as assessed by the Client Satisfaction Questionnaire
Tidsram: end of intervention (90 days)
|
This is an 8 item questionnaire.
Scores are summed across items once.
Items 2, 4, 5, and 8 are reverse scored.
Total scores range from 8 to 32, with the higher number indicating greater satisfaction
|
end of intervention (90 days)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Jason Burnett, PhD, The University of Texas Health Science Center, Houston
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
3 augusti 2026
Primärt slutförande (Beräknad)
3 augusti 2028
Avslutad studie (Beräknad)
3 augusti 2028
Studieregistreringsdatum
Först inskickad
19 augusti 2026
Först inskickad som uppfyllde QC-kriterierna
19 augusti 2026
Första postat (Faktisk)
24 augusti 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
24 augusti 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
19 augusti 2026
Senast verifierad
1 augusti 2026
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HSC-MS-26-0434
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .